You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Citation Tools

Article menu
Clinical/translational cancer immunotherapy
Original research
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Subudhi SK, Siddiqui BA, Aparicio AM, et al
Combined CTLA-4 and PD-L1 blockade in patients with chemotherapy-naïve metastatic castration-resistant prostate cancer is associated with increased myeloid and neutrophil immune subsets in the bone microenvironment
Journal for ImmunoTherapy of Cancer 2021;9:e002919. doi: 10.1136/jitc-2021-002919